134,073: the number of patents filed for via the Patent Cooperation Treaty in 2005, according to the World Intellectual Property Organization – a rise of 9.4 per cent over 2004.
French researchers have discovered that an anti-rejection drug could treat Huntington's disease. Intellectual Property based on the research is available for licence.
Researchers in Denmark have invented a bioplastic material made from dairy products that could replace traditional polymer-based packaging. The technology is currently available for licensing.
In the past five years the state of Saxony in the former East Germany has made great strides in creating a biosciences sector – outstripping progress made by some of its counterparts in the more prosperous west of the country.
TU Delft ditched the usual model of outlicensing or seeking venture capital backing when it was looking to commercialise a novel wastewater treatment technology.
Ireland's fastest-growing companies hired even more aggressively than other top job-creating European companies during 2001-2004, according to a survey conducted by Entrepreneurs for Growth, a membership-based organisation representing 2,000 European firms.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.